 |
|
 |
 |

Home > Company Index > Drugs > Drug Manufacturers - Major > Roche Group
 |
Roche Group |
 |
 |
 |
PROFILE |
 |
Roche is holding a handful. The company's more than 140 subsidiaries worldwide are devoted to drugs, vitamins, and diagnostic products. Its pharmaceuticals (more than 60% of sales) include antibiotic Rocephin; obesity treatment Xenical; AIDS drug Invirase; acne treatment Roaccutan/Accutane; and Tamiflu, which is used for prevention and treatment of influenza. OTC products include vitamins, the analgesic Aleve, and antacid Rennie. Roche is a leading maker of vitamins; owns 58% of biotech giant Genentech; and is the world's #1 diagnostics company. The company spun off fragrances and flavors unit Givaudan and a biotech division, which is now called BASILEA Pharmaceutica.
COMPETITION |
 |
Abbott Laboratories (ABT)
Aventis (AVE)
GlaxoSmithKline plc (GSK)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 17,791.00
1-Yr. Sales Growth: 2.7%
Employees: 64,758
Revenue per employee: $274,730.54
KEY PEOPLE |
 |
Franz B. Humer
CEO
CONTACT INFO |
 |
Grenzacherstrasse 124
CH-4070 Basel, Switzerland
Phone: 41-61-688-1111
Fax: 41-61-691-9391
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |